Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden

Clinical Cancer Research

Volumn 5, Issue 12, 1999, Pages 4273-4278

  Katzenstein, Howard M ^a,b   Rademaker, Alfred W ^b   Senger, Christof ^a   Salwen, Helen R ^b   Nguyen, Nadine N ^b   Thorner, Paul S ^c   Litsas, Louis ^c   Cohn, Susan L ^a,b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; FUMAGILLOL CHLOROACETYLCARBAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BODY BURDEN; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; GENE AMPLIFICATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR XENOGRAFT; XENOTRANSPLANTATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL DIVISION; CYCLOHEXANES; GROWTH INHIBITORS; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM STAGING; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NEUROBLASTOMA; SESQUITERPENES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0033378227     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
2. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
3. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994.
4. Srivastava, A., Laidler, P., Hughes, L. E., Woodcock, J., and Shedden, E. J. Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur. J. Cancer Clin. Oncol., 22: 1205-1209, 1986.
5. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
6. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., and Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst., 84: 1875-1887, 1992.
7. Macchiarini, P., Fontanini, G., Hardin, M. J., Squartini, F., and Angeletti, C. A. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet, 340: 145-146, 1992.
8. Maeda, K., Chung, Y-S., Takatsuka, S., Ogawa, Y., Sawada, T., Yamashita, Y., Onoda, N., Kato, Y., Nitta, A., Arimoto, Y., Kondo, Y., and Sowa, M. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J. Clin. Oncol., 13: 477-481, 1995.
9. Meitar, D., Crawford, S. E., Rademaker, A. W., and Cohn, S. L. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J. Clin. Oncol., 14: 405-414, 1996.
10. Castronovo, V., and Belotti, D. TNP-470 (AGM-1470): mechanisms of action and early clinical development. Eur. J. Cancer, 32A: 2520-2527, 1996.
11. Nagabuchi, E., Van der Kolk, W. E., Une, Y., and Ziegler, M. M. TNP-470 antiangiogenic therapy for advanced murine neuroblastoma. J. Pediatr. Surg., 32: 287-293, 1997.
12. Wassberg, E., Pahlman, S., Westlin, J. E., and Christofferson, R. The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats. Pediatr. Res., 41: 327-333, 1997.
13. Kragh, M., Spang-Thomsen, M., and Kristjansen, P. E. Time until initiation of tumor growth is an effective measure of the anti-angiogenic effect of TNP-470 on human glioblastoma in nude mice. Oncol. Rep., 6: 759-762, 1999.
14. Milkowski, D. M., and Weiss, R. A. TNP-470. In: B. A. Teicher (ed.), Antiangiogenic Agents in Cancer Therapy, pp. 385-398. Totowa, NJ: Human Press, 1999.
15. Stadler, W. M., Kuzel, T., Shapiro, C., Sosman, J., Clark, J., Vogelzang, N. J., and Abe, S. Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma. J. Clin. Oncol., 17: 2541-2545, 1999.
16. Foley, J., Cohn, S. L., Salwen, H. R., Chagnovich, D., Cowan, J., Mason, K. L., and Parysek, L. M. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line. Cancer Res., 51: 6338-6345, 1991.
17. Chen, S. Y., Yang, A. G., Chen, J. D., Kute, T., King, C. R., Collier, J., Cong, Y., Yao, C., and Huang, X. F. Potent antitumour activity of a new class of tumour-specific killer cells. Nature (Lond.), 385: 78-80, 1997.
18. Shimada, H., Chatten, J., Newton, W. A., Jr., Sachs, N., Hamoudi, A. B., Chiba, T., Marsden, H. B., and Misugi, K. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J. Natl. Cancer Inst., 73: 405-416, 1984.
19. Daniel, W. W. Biostatistics: A Foundation for Analysis in the Health Sciences. New York: Wiley, 1997.
20. Chagnovich, D., and Cohn, S. L. Binding of a 40-kDa protein to the N-myc 3′ untranslated region correlates with enhanced N-myc expression in human neuroblastoma. J. Biol. Chem., 271: 33580-33586, 1996.
21. Mori, S., Ueda, T., Kuratsu, S., Hosono, N., Izawa, K., and Uchida, A. Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma. Int. J. Cancer, 61: 148-152, 1995.
22. Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., and Folkman, J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature (Lond.), 348: 555-557, 1990.
23. Shimada, H., Ambros, I. M., Dehner, L. P., Hata, J., Joshi, V. V., and Roald, B. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer (Phila.), 86: 349-362, 1999.
24. Shimada, H., Ambros, I. M., Dehner, L. P., Hata, J., Joshi, V. V., Roald, B., Stram, D. O., Gerbing, R. B., Lukens, J. N., Matthay, K. K., and Castleberry, R. P. The International Neuroblastoma Pathology Classification (the Shimada System). Cancer (Phila.), 86: 364-372, 1999.
25. Bergers, G., Javaherian, K., Lo, K-M., Folkman, J., and Hanahan, D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science (Washington DC), 284: 808-812, 1999.
26. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (Lond.), 390: 404-407, 1997.